These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Non-alcoholic fatty liver disease - discussed under the light of Unani medicine. Riyazuddin M; Shahid A J Complement Integr Med; 2023 Mar; 20(1):17-23. PubMed ID: 34551462 [TBL] [Abstract][Full Text] [Related]
5. Understanding COVID-19 in the light of epidemic disease described in Unani medicine. Alam MA; Quamri MA; Sofi G; Ayman U; Ansari S; Ahad M Drug Metab Pers Ther; 2020 Sep; 35(4):. PubMed ID: 34704695 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic features of chronic migraine. Yalın OÖ; Uluduz D; Özge A; Sungur MA; Selekler M; Siva A J Headache Pain; 2016; 17():26. PubMed ID: 26975363 [TBL] [Abstract][Full Text] [Related]
8. The Perspective of Unani Medicine in Understanding Hyperthyroidism. Alam A; Sofi G; Quamri A Altern Ther Health Med; 2023 Oct; 29(7):262-267. PubMed ID: 36455141 [TBL] [Abstract][Full Text] [Related]
10. [Migrainous aura subtypes in hospitalized children]. Biedroń A; Steczkowska M; Zajac A; Stolarska U; Kroczka S Przegl Lek; 2009; 66(11):952-7. PubMed ID: 20297637 [TBL] [Abstract][Full Text] [Related]
11. Migraine symptoms: results of a survey of self-reported migraineurs. Silberstein SD Headache; 1995; 35(7):387-96. PubMed ID: 7672955 [TBL] [Abstract][Full Text] [Related]
12. Safety Evaluation of Unani Formulation: Capsule Shaqeeqa in Albino Wistar Rats. Ghazanfar K; Ahmad Dar S; Akbar S; Nazir T; Hamdani M; Siddiqui KM; Kumar P; Masood A Scientifica (Cairo); 2016; 2016():2683403. PubMed ID: 27190679 [TBL] [Abstract][Full Text] [Related]
13. Migraine headache in Sudan. Ibrahim EAA; Badri GAM; Ahmed KAHM; Omer MEA Brain Behav; 2021 Dec; 11(12):e2429. PubMed ID: 34775687 [TBL] [Abstract][Full Text] [Related]
14. Use of cluster analysis to validate IHS diagnostic criteria for migraine and tension-type headache. Bruehl S; Lofland KR; Semenchuk EM; Rokicki LA; Penzien DB Headache; 1999 Mar; 39(3):181-9. PubMed ID: 15613212 [TBL] [Abstract][Full Text] [Related]
15. Migraine changes with age: IMPACT on migraine classification. Kelman L Headache; 2006; 46(7):1161-71. PubMed ID: 16866720 [TBL] [Abstract][Full Text] [Related]
16. Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine. Ament M; Day K; Stauffer VL; Skljarevski V; Rettiganti M; Pearlman E; Aurora SK J Headache Pain; 2021 Feb; 22(1):6. PubMed ID: 33549036 [TBL] [Abstract][Full Text] [Related]
17. Understanding COVID-19 in the light of epidemic disease described in Unani medicine. Alam MA; Quamri MA; Sofi G; Ayman U; Ansari S; Ahad M Drug Metab Pers Ther; 2020 Sep; ():. PubMed ID: 32966232 [TBL] [Abstract][Full Text] [Related]
18. Body mass index and its association with various features of migraine: A cross-sectional study from Saudi Arabia. Aljaafari D; Ishaque N; Al-Shabeeb G; Alalwi S; Albakr A; Basheir O; Alyoubi RA; Alkhamis F; Alabdali M Ann Afr Med; 2021; 20(4):288-292. PubMed ID: 34893567 [TBL] [Abstract][Full Text] [Related]
19. Epileptic seizures and headache/migraine: a review of types of association and terminology. Cianchetti C; Pruna D; Ledda M Seizure; 2013 Nov; 22(9):679-85. PubMed ID: 23831147 [TBL] [Abstract][Full Text] [Related]